New combination of drugs works together to reduce lung tumors in mice



New combination of drugs works together to reduce lung tumors in mice

A new study has revealed FDA-approved trametinib and entinostat (which is currently in clinical trials) can be given in tandem to produce fewer and smaller tumors in mice with LKB1-mutated non-small cell lung cancer.

Materials provided by Salk Institute. Note: Content may be edited for style and length.




Source link aaaaa

Related posts

17th March 2023

Study offers a potential strategy to improve T cell therapy in solid tumors

Read more
17th March 2023

Researchers chart a course for understanding, preventing, and treating young-onset colorectal cancer

Read more
17th March 2023

DNA treatment could delay paralysis that strikes nearly all patients with ALS

Read more